HCW Biologics Inc (HCWB)

HCW Biologics Inc (HCWB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.8M; returns 1 day +4.5%, 1 week -5.6%, 1 year -95.0%.

HCW Biologics Inc. is a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies. Its primary mission is to extend healthspan by disrupting the link between chronic inflammation and age-related diseases, a field often referred to as 'inflammaging'.

Groups HCWB belongs to

• Biotechnology
• Recent Reverse Splits
• Clinical Stage Biotech
• Immunotherapy
• Healthcare
• Chronic Inflammatory Diseases
• Oncology
• Autoimmune Diseases
• Biopharmaceutical
• Alopecia Areata
• Aging Population Needs

HCWB financial model: income statement, cash flow and balance sheet